[][com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=86883]], camposKey:1661-6596 2024-08-01 Obesity-Associated Colorectal Cancer00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=88614]], camposKey:1661-6596 2024-01-01 Mineralocorticoid Receptor and Sleep Quality in Chronic Kidney Disease00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=75300]], camposKey:1661-6596 2023-04-01 Involvement of Bcl-2 Family Proteins in Tetraploidization-Related Senescence00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=82858]], camposKey:2234-943X 2023-01-01 Multiomics insights on the onset, progression, and metastatic evolution of breast cancer00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=73595]], camposKey:0027-8424 2022-10-11 ACBP/DBI protein neutralization confers autophagy-dependent organ protection through inhibition of cell loss, inflammation, and fibrosis00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=73597]], camposKey:2041-4889 2021-11-01 Everolimus and plicamycin specifically target chemoresistant colorectal cancer cells of the CMS4 subtype00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=73596]], camposKey:2041-4889 2021-11-01 Paradoxical implication of BAX/BAK in the persistence of tetraploid cells00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=73579]], camposKey:1064-3745 2021-01-01 In Vivo Imaging of Orthotopic Lung Cancer Models in Mice199212, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=73598]], camposKey:2041-1723 2020-12-01 Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancer00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=73580]], camposKey:2041-1723 2020-09-17 Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancer (July, 10.1038/s41467-020-17644-0, 2020)00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=73581]], camposKey:2162-402X 2019-11-02 Lurbinectedin synergizes with immune checkpoint blockade to generate anticancer immunity00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=58990]], camposKey:2162-4011 2019-11-02 Suppression of tumor antigen presentation during aneuploid tumor evolution contributes to immune evasion00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=73582]], camposKey:2041-1723 2019-04-17 Crizotinib-induced immunogenic cell death in non-small cell lung cancer (vol 10, 1486, 2019)00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=73583]], camposKey:2041-1723 2019-04-02 Crizotinib-induced immunogenic cell death in non-small cell lung cancer00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=58991]], camposKey:2162-4011 2018-08-03 Immune effectors responsible for the elimination of hyperploid cancer cells00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=58992]], camposKey:1350-9047 2018-08-01 eIF2¿ phosphorylation is pathognomonic for immunogenic cell death13751393, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41124]], camposKey:0143-4160 2018-01-01 Calcium signaling and cell cycle: Progression or death315, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=58993]], camposKey:0105-2896 2017-11-01 Immunogenic stress and death of cancer cells: Contribution of antigenicity vs adjuvanticity to immunosurveillance165174, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=73585]], camposKey:1064-3745 2017-01-01 Image Cytofluorometry for the Quantification of Ploidy and Endoplasmic Reticulum Stress in Cancer Cells5364, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=58994]], camposKey:2162-4011 2016-10-02 The ratio of CD8+/FOXP3 T lymphocytes infiltrating breast tissues predicts the relapse of ductal carcinoma in situ00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=58995]], camposKey:1535-6108 2016-07-11 Caloric Restriction Mimetics Enhance Anticancer Immunosurveillance147160, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=58997]], camposKey:2162-4011 2016-06-02 Biomarkers of immunogenic stress in metastases from melanoma patients: Correlations with the immune infiltrate00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=58996]], camposKey:2162-4011 2016-06-02 Inhibition of formyl peptide receptor 1 reduces the efficacy of anticancer chemotherapy against carcinogen-induced breast cancer00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=58998]], camposKey:2162-4011 2016-06-02 Positive impact of autophagy in human breast cancer cells on local immunosurveillance00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=58999]], camposKey:1554-8627 2016-05-03 The presence of LC3B puncta and HMGB1 expression in malignant cells correlate with the immune infiltrate in breast cancer864875, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=73587]], camposKey:2041-4889 2016-03-01 The oncolytic peptide LTX-315 triggers immunogenic cell death00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=59000]], camposKey:1078-8956 2015-10-07 Natural and therapy-induced immunosurveillance in breast cancer11281138, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=73584]], camposKey:2405-8025 2015-10-01 Karyotypic Aberrations in Oncogenesis and Cancer Therapy124135, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=59001]], camposKey:0950-9232 2015-06-04 Immune-dependent antineoplastic effects of cisplatin plus pyridoxine in non-small-cell lung cancer30533062, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=73599]], camposKey:2331-4737 2015-01-01 Chemosensitization strategies for the treatment of lung cancer833834, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=59002]], camposKey:1554-8627 2015-01-01 Combined evaluation of LC3B puncta and HMGB1 expression predicts residual risk of relapse after adjuvant chemotherapy in breast cancer18781890, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=59003]], camposKey:1044-579X 2015-01-01 EIF2¿ phosphorylation as a biomarker of immunogenic cell death8692, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=73600]], camposKey:1949-2553 2015-01-01 Morphometric analysis of immunoselection against hyperploid cancer cells4120441215, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=38041]], camposKey:2234-943X 2015-01-01 Single-cell phenotypic characterization of human pituitary ghomas and non-functioning adenomas based on hormone content and calcium responses to hypothalamic releasing hormones00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=59004]], camposKey:2162-4011 2014-10-01 Consensus guidelines for the detection of immunogenic cell death00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=73588]], camposKey:2162-4011 2014-09-01 Vitamin B6 improves the immunogenicity of cisplatin-induced cell death00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=59005]], camposKey:1538-4101 2014-06-15 Coffee induces autophagy in vivo19871994, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=59006]], camposKey:1097-2765 2014-03-06 Regulation of Autophagy by Cytosolic Acetyl-Coenzyme A710725, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=59007]], camposKey:0027-8424 2014-02-25 Resveratrol and aspirin eliminate tetraploid cells for anticancer chemoprevention30203025, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=59011]], camposKey:1350-9047 2014-01-01 Autophagy inhibition radiosensitizes in vitro, yet reduces radioresponses in vivo due to deficient immunogenic signalling9299, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=73601]], camposKey:1949-2553 2014-01-01 Classification of current anticancer immunotherapies1247212508, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=59010]], camposKey:1350-9047 2014-01-01 Immunogenic calreticulin exposure occurs through a phylogenetically conserved stress pathway involving the chemokine CXCL85968, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=73602]], camposKey:1949-2553 2014-01-01 Immunogenic cell death inducers as anticancer agents51905191, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=59009]], camposKey:0952-7915 2014-01-01 Impact of myeloid cells on the efficacy of anticancer chemotherapy2431, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=59008]], camposKey:2162-4011 2014-01-01 Screening of novel immunogenic cell death inducers within the NCI mechanistic diversity set00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=59012]], camposKey:1350-9047 2013-11-01 Characterization of novel MPS1 inhibitors with preclinical anticancer activity15321545, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=59013]], camposKey:0950-9232 2013-10-01 Effects of vitamin B6 metabolism on oncogenesis, tumor progression and therapeutic responses49955004, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=59014]], camposKey:1471-4906 2013-10-01 Immunosurveillance as a regulator of tissue homeostasis471481, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=59015]], camposKey:1359-6101 2013-08-01 Crosstalk between ER stress and immunogenic cell death311318, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=73589]], camposKey:0008-5472 2013-04-15 Targeting tetraploidy for cancer therapy by pharmacological and immunological strategies.00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=59016]], camposKey:1687-8876 2013-04-03 Functions of BCL-XL at the interface between cell death and metabolism00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=59018]], camposKey:0008-5472 2013-04-01 Cisplatin resistance associated with PARP hyperactivation22712280, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=59017]], camposKey:2162-4011 2013-04-01 Trial watch: DNA vaccines for cancer therapy00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=59019]], camposKey:1538-4101 2013-03-15 Synergistic interaction between cisplatin and PARP inhibitors in non-small cell lung cancer877883, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=59020]], camposKey:2162-4011 2013-03-01 Trial watch: Chemotherapy with immunogenic cell death inducers00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=59021]], camposKey:1538-4101 2013-02-15 Prognostic value of LIPC in non-small cell lung carcinoma647654, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=59022]], camposKey:1538-4101 2013-02-01 Immunosurveillance against tetraploidization-induced colon tumorigenesis473479, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=59023]], camposKey:1538-4101 2013-02-01 Vitamin B6 metabolism influences the intracellular accumulation of cisplatin417421, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=73590]], camposKey:2162-402X 2013-01-01 An anticancer therapy-elicited immunosurveillance system that eliminates tetraploid cells00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=59026]], camposKey:1554-8627 2013-01-01 Direct interaction between STAT3 and EIF2AK2 controls fatty acid-induced autophagy415417, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=59027]], camposKey:0077-8923 2013-01-01 Immunological control of cell cycle aberrations for the avoidance of oncogenesis: The case of tetraploidy5761, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=59024]], camposKey:1945-4589 2013-01-01 Immunostimulatory activity of lifespan-extending agents793801, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=59028]], camposKey:1097-2765 2012-12-14 Cytoplasmic STAT3 Represses Autophagy by Inhibiting PKR Activity667680, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=59029]], camposKey:2162-4011 2012-12-01 Trial watch: Dendritic cell-based interventions for cancer therapy11111134, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=59030]], camposKey:2162-4011 2012-12-01 Trial watch prognostic and predictive value of the immune infiltrate in cancer13231343, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=73591]], camposKey:2211-1247 2012-11-01 Prognostic Impact of Vitamin B6 Metabolism in Lung Cancer (vol 2, pg 257, 2012)14721472, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=59031]], camposKey:1538-4101 2012-10-15 Erratum: Chemotherapy induces ATP release from tumor cells (Cell Cycle (2009) 8:22 (3723-3728))00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=59032]], camposKey:0036-8075 2012-09-28 An immunosurveillance mechanism controls cancer cell ploidy16781684, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=59033]], camposKey:1538-4101 2012-09-15 Independent transcriptional reprogramming and apoptosis induction by cisplatin34723480, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=73592]], camposKey:1742-464X 2012-09-01 Autophagy as an active contributor to micronuclei clearance5656, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=59034]], camposKey:1538-4101 2012-09-01 Tetraploid cancer cell precursors in ovarian carcinoma31573158, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=73593]], camposKey:2211-1247 2012-08-01 Prognostic Impact of Vitamin B6 Metabolism in Lung Cancer257269, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=59035]], camposKey:0950-9232 2012-07-06 Antineoplastic activity of ouabain and pyrithione zinc in acute myeloid leukemia35363546, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=59036]], camposKey:1538-4101 2012-06-01 Preferential killing of p53-deficient cancer cells by reversine21492158, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=59037]], camposKey:1757-4676 2012-06-01 Selective killing of p53-deficient cancer cells by SP600125500514, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=73586]], camposKey:0008-5472 2012-04-15 PARP overactivation predicts the susceptibility of human cancer cells to apoptosis induction by PARP inhibitors00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=59038]], camposKey:0950-9232 2012-04-12 Molecular mechanisms of cisplatin resistance18691883, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=59039]], camposKey:1474-1776 2012-03-01 The secret ally: Immunostimulation by anticancer drugs215233, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=59040]], camposKey:1538-4101 2012-01-01 Autophagic removal of micronuclei170176, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=73603]], camposKey:1949-2553 2012-01-01 Immunosurveillance against cancer-associated hyperploidy12701271, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=59041]], camposKey:1350-9047 2011-09-01 Illicit survival of cancer cells during polyploidization and depolyploidization14031413, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=59042]], camposKey:1064-3745 2011-08-04 Cytofluorometric purification of diploid and tetraploid cancer cells4763, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=59043]], camposKey:1538-4101 2010-07-15 In vivo depletion of T lymphocyte-specific transcription factors by RNA interference29022907, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=59044]], camposKey:1538-4101 2010-07-15 Involvement of p38¿ in the mitotic progression of p53-/- tetraploid cells28952901, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=59045]], camposKey:1078-0432 2010-06-15 Immunogenic tumor cell death for optimal anticancer therapy: The calreticulin exposure pathway31003104, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=59046]], camposKey:0954-6820 2010-05-01 Viral strategies for the evasion of immunogenic cell death: Symposium526542, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=59047]], camposKey:0261-4189 2010-04-01 Multipolar mitosis of tetraploid cells: Inhibition by p53 and dependency on Mos12721284, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=59048]], camposKey:0008-5472 2010-03-01 miR-181a and miR-630 regulate cisplatin-induced cancer cell death17931803, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=73594]], camposKey:2041-4889 2010-02-01 An automated fluorescence videomicroscopy assay for the detection of mitotic catastrophe00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=59049]], camposKey:0261-4189 2010-02-01 The IKK complex contributes to the induction of autophagy619631, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=59051]], camposKey:1554-8627 2010-01-01 IKK connects autophagy to major stress pathways189191, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=59050]], camposKey:0077-8923 2010-01-01 Surface-exposed calreticulin in the interaction between dying cells and phagocytes7782, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=59052]], camposKey:1538-4101 2009-11-15 Chemotherapy induces ATP release from tumor cells37233728, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=59053]], camposKey:1538-4101 2009-05-01 p53 represses the polyploidization of primary mammary epithelial cells by activating apoptosis13801385, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=59055]], camposKey:1360-8185 2009-04-01 Immunogenic cell death modalities and their impact on cancer treatment364375, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=59054]], camposKey:1538-4101 2009-04-01 Preferential killing of tetraploid tumor cells by targeting the mitotic kinesin Eg510301035, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=59056]], camposKey:1538-4101 2009-03-15 Viral subversion of immunogenic cell death860869, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=59057]], camposKey:0950-9232 2008-07-10 Hierarchical involvement of Bak, VDAC1 and Bax in cisplatin-induced cell death42214232, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=59059]], camposKey:1538-4101 2008-07-01 Chk1 inhibition activates p53 through p38 MAPK in tetraploid cancer cells19561961, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=59058]], camposKey:0008-5472 2008-07-01 Improved cellular pharmacokinetics and pharmacodynamics underlie the wide anticancer activity of sagopilone53015308, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=38333]], camposKey:0013-7227 2008-01-01 Rapid changes in anterior pituitary cell phenotypes in male and female mice after acute cold stress21592167, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=39439]], camposKey:0143-4160 2008-01-01 The role of mitochondrial potential in control of calcium signals involved in cell proliferation259269, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=73577]], camposKey:1932-6203 2007-12-26 Inhibition of Chk1 Kills Tetraploid Tumor Cells through a p53-Dependent Pathway00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=38339]], camposKey:0022-3751 2007-01-01 Bioluminescence imaging of mitochondrial Ca2+ dynamics in soma and neurites of individual adult mouse sympathetic neurons385395, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=38342]], camposKey:0022-3751 2006-01-01 Cell proliferation depends on mitochondrial Ca2+ uptake: Inhibition by salicylate5773, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=73578]], camposKey:0006-3363 2006-01-01 Multifunctional cells of the anterior pituitary depend on the age-related endocrine state and sex.6767, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=38220]], camposKey:0021-972X 2004-01-01 Multifunctional cells in human pituitary adenomas: Implications for paradoxical secretion and tumorigenesis45454552, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=38349]], camposKey:0022-3751 2003-01-01 Multifunctional cells of mouse anterior pituitary reveal a striking sexual dimorphism835843][][][][][][][][com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=65801]], com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=64645]], com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=64080]], com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=62925]], com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=64546]]][com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=65801]], com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=64645]], com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=64080]], com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=62925]], com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=64546]]][][][][][][][][][][][com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@870fce8][][][][][][][][][][com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@56f250], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@4618ca]][][][][][][][com.sigma.fs3.argos.domain.gpc.altres.ProjecteInnovacio@16d50][]
